Skip to content

The effect of cognitive behavioral therapy on insomnia and anxiety of people addicted to opioids

The Effectiveness Of Cognitive Behavioral Therapy Combined With Gradual Tapering Of Benzodiazepine Use On Insomnia And Anxiety In Persons With Opioid Use Disorder

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240821062830N1
Enrollment
40
Registered
2025-10-02
Start date
2024-02-14
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Opioid Use Disorder. Condition 2: Insomnia. Condition 3: Anxiety.

Interventions

Intervention 1: Intervention group: Cognitive Behavioral Therapy Combined With Gradual Tapering Of Benzodiazepine Use :Cognitive behavioral group psychotherapy, consisting of 9 therapy sessions (each

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: being male Daily benzodiazepine use at bedtime for the past 3 months or more A diagnosis of chronic insomnia defined as insomnia for a period of 6 months or longer according to the Sleep Disorders Association of America Not having severe physical illness (such as cancer, AIDS, multiple sclerosis) Not being exposed to psychological training at the same time

Exclusion criteria

Exclusion criteria: The existence of an unpleasant incident in the last few months Use of a non-benzodiazepine hypnotic Alcohol abuse Absence of more than two sessions in treatment Use of opioids

Design outcomes

Primary

MeasureTime frame
Insomnia severity score. Timepoint: pre-test, mid-test (4 weeks), post-test (9 weeks) and follow-up test (3 months). Method of measurement: SI Insomnia Severity Index Standard Questionnaire.;Reduce anxiety. Timepoint: pre-test, mid-test (4 weeks), post-test (9 weeks) and follow-up test (3 months). Method of measurement: Beck Anxiety Inventory (BAI).;Stop taking benzodiazepines. Timepoint: pre-test, mid-test (4 weeks), post-test (9 weeks) and follow-up test (3 months). Method of measurement: Blood and urine tests and checking the doctor's prescription.;Tapering Of Benzodiazepine Use. Timepoint: pre-test, mid-test (4 weeks), post-test (9 weeks) and follow-up test (3 months). Method of measurement: Blood and urine tests and checking the doctor's prescription.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Ghorbanpour Ahmadsargourabi

Islamic Azad University

farzaneh_ghorbanpour@yahoo.com+98 13 3326 2601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026